Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Dobbie
Nivolumab in Chemotherapy-Resistant Cervical Cancer: Report of a Vulvitis as a Novel Immune-Related Adverse Event and Molecular Analysis of a Persistent Complete Response
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Pericardial Effusion With Tamponade, an Immune-Related Adverse Event Associated With Nivolumab Therapy: A Case Report and Review of the Literature
Journal of Cancer Therapy
819 Extragenital Lichen Sclerosus Is an Immune-Related Adverse Event With Nivolumab
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
Cancer Immunotherapy: Imaging Assessment of Novel Treatment Response Patterns and Immune-Related Adverse Events
Radiographics
Medicine
Nuclear Medicine
Radiology
Imaging
Delayed Immune-Related Erythrodermia in a Squamous NSCLC Patient Treated With Nivolumab: A Case Report
Journal of Cancer Research and Immuno-Oncology
A Case of Advanced Gastric Cancer Achieved a Pathological Complete Response by Chemotherapy
Surgical Case Reports
A Novel Adverse Event of Nusinersen Treatment: Thrombocytosis
Indian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Clinical Complete Response From Chemotherapy in an Elderly Patient With Metastatic Gastric Cancer: A Case Report
Journal of Nippon Medical School
Medicine
Pathological Complete Response After Neoadjuvant Chemotherapy With Trastuzumab-Containing Regimen in Gastric Cancer: A Case Report
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
